Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?
Author:
Publisher
Elsevier BV
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference48 articles.
1. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015
2. Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes;Riddle;Diabetes Care,2011
3. Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings;Holst;Diabetes Obes Metab,2013
4. Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature;Balena;Diabetes Obes Metab,2013
5. Combining incretin-based therapies with insulin. Realizing the potential in type 2 diabetes;Vora;Diabetes Care,2013
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Underutilization of insulin and better metabolic control. A NOVA clinic experience;Revista da Associação Médica Brasileira;2020-03
2. Preparation, characterization and anti-diabetic activity of polysaccharides from adlay seed;International Journal of Biological Macromolecules;2019-10
3. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets;Annals of Medicine;2018-08-18
4. Intensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study;Current Therapeutic Research;2018
5. Comparing Clinical Outcomes and Costs for Different Treatment Intensification Approaches in Patients with Type 2 Diabetes Uncontrolled On Basal Insulin: Adding Glucagon-Like Peptide 1 Receptor Agonists Versus Adding Rapid-Acting Insulin or Increasing Basal Insulin Dose;Endocrine Practice;2017-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3